Skip to main content
SpringerLink
Log in

Explanatory Notes General

  • Chapter
TNM Supplement 1993

  • 37 Accesses

Abstract

Two classifications are described for each site, namely:

  1. a)

    Clinical classification (Pretreatment clinical classification), designated TNM (or cTNM). This is based on evidence acquired before treatment. Such evidence arises from physical examination, imaging, endoscopy, biopsy, surgical exploration and other relevant examinations.

  2. b)

    Pathological classification (Postsurgical histopathological classification), designated pTNM. This is based on the evidence acquired before treatment, supplemented or modified by the additional evidence acquired from surgery and from pathological examination. The pathological assessment of the primary tumour (pT) entails a resection of the primary tumour or biopsy adequate to evaluate the highest pT category. The pathological assessment of the regional lymph nodes (pN) entails removal of nodes adequate to validate the absence of regional lymph node metastasis (pN0) and sufficient to evaluate the highest pN category. The pathological assessment of distant metastasis (pM) entails microscopic examination.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Anneroth G. Hansen LS (1984) A methodologic study of histologic classification and grading of malignancy in oral squamous cell carcinoma. Scand J Dent Res 92: 448–468

    PubMed  CAS  Google Scholar 

  • Anneroth G, Batsakis J, Luna M (1987) Review of the literature and a recommended system of malignancy grading in oral squamous cell carcinoma. Scand J Dent Res 95: 229–249

    PubMed  CAS  Google Scholar 

  • Bloom HJG, Richardson WW (1957) Histologic grading and prognosis in breast cancer. Br J Cancer 11: 359–377

    Article  PubMed  CAS  Google Scholar 

  • Bryne M, Koppang HS, Lilleng R. Stene T, Bang G, Dabelsteen E (1989) New malignancy grading is a better prognostic indicator than Broders’ grading in oral squamous cell carcinomas. J Oral Pathol Med 18: 432–437

    Article  PubMed  CAS  Google Scholar 

  • Coindre JM, Trojan M, Contesso G et al. (1986) Reproducibility of a histopathological grading system for adult tissue sarcoma. Cancer 58: 306–309

    Article  PubMed  CAS  Google Scholar 

  • Enzinger FM, Weiss SW (1988) Soft tissue tumors, 2nd edn, Mosby, St. Louis

    Google Scholar 

  • Gleason DF, Veterans Administration Cooperative Urological Research Group (VACURG) (1977) Histologic grading and clinical staging of prostatic carcinoma. In: Tannenbaum M (ed) Urologie pathology: the prostate. Lea and Febiger, Philadelphia

    Google Scholar 

  • Henson DE, Ries L, Freedman LS, Carriaga M (1991) Relationship among outcome, stage of disease, and histologic grade for 22 616 cases of breast cancer. Cancer 68: 2142–2149

    Article  PubMed  CAS  Google Scholar 

  • Jaehne J, Meyer HJ. Soudah B, Maschek H, Pichlmayr R (1989) Peritoneal lavage in gastric carcinoma. Dig Surg 6: 26–28

    Google Scholar 

  • Japanese Research Society for Gastric Cancer (1993) The general rules for gastric cancer study. 12th ed. (in Japanese). Kanahare Public Co Ltd, Tokyo

    Google Scholar 

  • Jass JR, Sobin LH (1989) Histological typing of intestinal tumours, 2nd edn. WHO International Histological Classification of Tumours. Springer, Berlin Heidelberg New York

    Book  Google Scholar 

  • Martin JK Jr, Goellner JR (1986) Abdominal fluid cytology in patients with gastrointestinal malignant lesions. Mayo Clin Proc 61: 467–471

    PubMed  Google Scholar 

  • Maruyama K (1991) Diagnosis of invisible peritoneal metastasis: cytologic examination by peritoneal lavage. In: Cordiano C, de Manzoni G (eds) Staging and treatment of gastric cancer. Piccin Nuova Libraria, Padua, pp 180–181

    Google Scholar 

  • Müller HA, Alternähr E, Böcking A, Dhom G, Faul P, Göttinger H, Helpap B, Hohbach C, Kastendieck H, Leistenschneider G (1980) Über Klassifikation and Grading des Prostatacarcinomas. Verh Dtsch Ges Path 64: 609–611

    Google Scholar 

  • Nakajima T, Harashima S, Hirata M, Kajitani T (1978) Prognostic and therapeutic values of peritoneal cytology in gastric cancer. Acta Cytol 22: 225–229

    PubMed  CAS  Google Scholar 

  • Scheele J, Stangl R, Altendorf-Hofmann A, Gall FP (1990) Indicators of prognosis after hepatic resection for colorectal secondaries. Surgery 110: 13–29

    Google Scholar 

  • Schnürch HG, Lange C, Bender HG (1989) Vier histopathologische Differenzierungsgrade beim Mammakarzinom? Pathologe 10: 39–42

    PubMed  Google Scholar 

  • SEER Program (1992) Code manual. Revised edition June 1992 (Cunningham J, Ries L, Hankey B, Seiffert J, Lyles B, Shambaugh E, Percy C, van Holten V, eds) NIH Publication No 92–1999. National Cancer Institute, Bethesda

    Google Scholar 

  • Veronesi U, Farante G, Galimberti V, Greco M, Luini A, Sacchini V, Andreola S, Leoni F, Ménard S, Ronco M, Colnaghi MI (1991) Evaluation of resection margins after breast conservative surgery with monoclonal antibodies. EurJ Surg Oncol 17: 338–341

    CAS  Google Scholar 

  • Warshaw AL (1991) Implications of peritoneal cytology for staging of early pancreatic cancer. Am J Surg 161: 26–30

    Article  PubMed  CAS  Google Scholar 

  • Zeng Z, Cohen AM, Hajdu S, Sternberg SS, Sigurdson ER, Enker W (1992) Serosal cytologic study to determine free mesothelial penetration by intraperitoneal colon cancer. Cancer 70: 737–740

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Chirurgische Universitätsklinik Erlangen, Maximiliansplatz, 91054, Erlangen, Germany

    Professor Dr. P. Hermanek (Vorstand der Abteilung für Klinische Pathologie i. R.)

  2. Early Detection Branch, Division of Cancer Prevention and Control, National Cancer Institute, 20892, Bethesda, MD, USA

    Dr. D. E. Henson

  3. New Jersey Medical School, University of Medicine and Dentistry, Newark, NJ, USA

    Dr. R. V. P. Hutter (Clinical Professor of Pathology)

  4. Department of Pathology, Saint Barnabas Medical Center, Old Short Hills Road, 07039, Livingston, NJ, USA

    Dr. R. V. P. Hutter (Clinical Professor of Pathology)

  5. Uniformed Services University of the Health Sciences, Bethesda, MD, USA

    Dr. L. H. Sobin (Professor of Pathology)

  6. Division of Gastrointestinal Pathology, Armed Forces Institute of Pathology, 20306, Washington, DC, USA

    Dr. L. H. Sobin (Professor of Pathology)

Authors
  1. Professor Dr. P. Hermanek
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dr. D. E. Henson
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dr. R. V. P. Hutter
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Dr. L. H. Sobin
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Chirurgische Universitätsklinik Erlangen, Maximiliansplatz, 91054, Erlangen, Germany

    P. Hermanek (Vorstand der Abteilung für Klinische Pathologie i. R.) (Vorstand der Abteilung für Klinische Pathologie i. R.)

  2. Early Detection Branch, Division of Cancer Prevention and Control, National Cancer Institute, 20892, Bethesda, MD, USA

    D. E. Henson

  3. New Jersey Medical School, University of Medicine and Dentistry, Newark, NJ, USA

    R. V. P. Hutter (Clinical Professor of Pathology) (Clinical Professor of Pathology)

  4. Department of Pathology, Saint Barnabas Medical Center, Old Short Hills Road, 07039, Livingston, NJ, USA

    R. V. P. Hutter (Clinical Professor of Pathology) (Clinical Professor of Pathology)

  5. Uniformed Services University of the Health Sciences, Bethesda, MD, USA

    L. H. Sobin (Professor of Pathology) (Professor of Pathology)

  6. Division of Gastrointestinal Pathology, Armed Forces Institute of Pathology, 20306, Washington, DC, USA

    L. H. Sobin (Professor of Pathology) (Professor of Pathology)

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Hermanek, P., Henson, D.E., Hutter, R.V.P., Sobin, L.H. (1993). Explanatory Notes General. In: Hermanek, P., Henson, D.E., Hutter, R.V.P., Sobin, L.H. (eds) TNM Supplement 1993. UICC International Union Against Cancer / Union Internationale Contre le Cancer. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-46792-9_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-46792-9_1

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-56556-7

  • Online ISBN: 978-3-642-46792-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation